Menlo Therapeutics Inc. (NASDAQ:MNLO) has seen 14,392,142 shares traded in the last trading session. The company, currently valued at $293.34 Million, closed the last trade at $1.75 per share which meant it lost -$0.1 on the day or -9.79% during that session. The MNLO stock price is -327.43% off its 52-week high price of $7.48 and 42.86% above the 52-week low of $1. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.87 Million shares traded. The 3-month trading volume is 5.31 Million shares.

The consensus among analysts is that Menlo Therapeutics Inc. (MNLO) is a Buy stock at the moment, with a recommendation rating of 1.9. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 8 have rated it as a Hold, with 8 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.23.

Menlo Therapeutics Inc. (NASDAQ:MNLO) trade information

Despite being -9.79% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 22 when the MNLO stock price touched $2.3299 or saw a rise of 24.89%. Year-to-date, Menlo Therapeutics Inc. shares have moved -62.28%, while the 5-day performance has seen it change -24.89%. Over the past 30 days, the shares of Menlo Therapeutics Inc. (NASDAQ:MNLO) have changed -27.08%. Short interest in the company has seen 6.94 Million shares shorted with days to cover at 1.31.

Wall Street analysts have a consensus price target for the stock at $6.56, which means that the shares’ value could jump 274.86% from current levels. The projected low price target is $2.5 while the price target rests at a high of $15. In that case, then, we find that the current price level is +757.14% off the targeted high while a plunge would see the stock lose 42.86% from current levels.

Menlo Therapeutics Inc. (MNLO) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -30.3% while over the next 5 years, the company’s earnings are expected to increase by 0%.

Menlo Therapeutics Inc. (NASDAQ:MNLO)’s Major holders

Insiders own 4.62% of the company shares, while shares held by institutions stand at 14.27% with a share float percentage of 14.96%. Investors are also buoyed by the number of investors in a company, with Menlo Therapeutics Inc. having a total of 103 institutions that hold shares in the company. The top two institutional holders are Perceptive Advisors Llc with over 6.64 Million shares worth more than $17.79 Million. As of March 30, 2020, Perceptive Advisors Llc held 4.87% of shares outstanding.

The other major institutional holder is Vivo Capital, LLC, with the holding of over 3.84 Million shares as of March 30, 2020. The firm’s total holdings are worth over $10.3 Million and represent 2.82% of shares outstanding.